Immatics (IMTX) Current Deferred Revenue (2019 - 2025)

Immatics' (IMTX) quarterly Current Deferred Revenue came in at $21.6 million in Q4 2025, down 43.75% year-on-year from $38.4 million in Q4 2024, and down 27.78% quarter-over-quarter from $29.9 million in Q3 2025.

Immatics (IMTX) Current Deferred Revenue (2019 - 2025) Analysis & Trends

Immatics has disclosed Current Deferred Revenue across 7 years of filings, most recently posting $21.6 million for Q4 2025.

  • Current Deferred Revenue for Q4 2025 came in at $21.6 million, down 43.75% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.6 million (down 43.75% YoY), and the FY2025 annual result was $20.9 million, down 45.41% from the prior year.
  • Current Deferred Revenue came in at $21.6 million for Q4 2025 at Immatics, down from $29.9 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $124.3 million in Q4 2023 to a low of $21.6 million in Q4 2025.
  • The 5-year median for Current Deferred Revenue is $73.5 million (2021), against an average of $71.6 million.
  • Across the five-year window, Current Deferred Revenue jumped 87.56% in 2023 and slumped 70.74% in 2025, its largest moves.
  • Immatics' Current Deferred Revenue stood at $57.7 million in 2021, then advanced by 14.94% to $66.3 million in 2022, then surged by 87.56% to $124.3 million in 2023, then slumped by 69.13% to $38.4 million in 2024, then slumped by 43.75% to $21.6 million in 2025.
  • The last three Current Deferred Revenue figures came in at $21.6 million (Q4 2025), $29.9 million (Q3 2025), and $31.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Immatics 14.67 Bn 14.67 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 21.58 Mn
Sep 30, 2025 29.88 Mn
Jun 30, 2025 31.20 Mn
Mar 31, 2025 30.68 Mn
Dec 31, 2024 38.37 Mn
Sep 30, 2024 75.70 Mn
Jun 30, 2024 102.87 Mn
Mar 31, 2024 104.86 Mn
Dec 31, 2023 124.30 Mn
Sep 30, 2023 67.55 Mn
Jun 30, 2023 74.04 Mn
Mar 31, 2023 70.07 Mn
Dec 31, 2022 66.27 Mn
Sep 30, 2022 104.07 Mn
Jun 30, 2022 123.05 Mn
Mar 31, 2022 76.08 Mn
Dec 31, 2021 57.66 Mn
Sep 30, 2021 72.97 Mn
Jun 30, 2021 74.91 Mn
Mar 31, 2021 86.50 Mn